These data extend the findings from that prior report and show that GPER protein is expressed in a high percentage of colon, pancreatic, melanoma, and lung cancer cases, consistent with reports showing efficacy in these preclinical models (3, 4, 17–19). Here, GPER1 is linked to lung carcinoma.